Sarah Monime
Darwin Global Management, Ltd.
Assets Managed
$3.771B
Holdings
6
Last Quarter
2026 - Q1
Filed Date
1mo 5d ago
Growth Rate
-23.66%(2Q avg: 6.82%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Darwin Global Management, Ltd.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 6 positions.
Assets under management
The assets under management (AUM) of Darwin Global Management, Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 3.771B in assets, with a quarterly growth rate of -23.66% and a 2-quarter average growth rate of 6.82%. The portfolio is managed by Sarah Monime, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
INSM Insmed Inc
| 68.34% | $2.577B 16.805M shares@ $153.33 avg price | Decreased -19.72% |
BLTE Belite Bio Inc - Adr
| 12.1% | $456.105M 3.057M shares@ $149.18 avg price | Increased 0.99% |
ABVX Abivax Sa-adr
| 9.34% | $352.069M 3.469M shares@ $101.51 avg price | Increased 9.13% |
RVMD Revolution Medicines Inc
| 5.44% | $204.983M 2.211M shares@ $92.72 avg price | New Position |
ROIV Roivant Sciences Ltd
| 4.77% | $179.517M 6.797M shares@ $26.41 avg price | New Position |
DNTH Dianthus Therapeutics Inc
| 0.04% | $1.457M 17,357 shares@ $83.92 avg price | New Position |
1-6 of 6